The deal is a strategic partnership between the companies that will strengthen their nutraceutical ingredients platforms and expand the Solabia Group’s presence in the U.S. market. Solabia’s scientific capabilities and established market presence in Europe will support ENI’s continued growth and development across the region, the companies said in a statement.
Solabia is a vertically integrated manufacturer of natural active ingredients for the cosmetics, nutraceutical, pharmaceutical and biotechnology industries. The company operates nine production facilities and several R&D centers, with a presence across North and South America, Asia, the Middle East and Africa.
ENI has established a position in the U.S. nutraceutical market with a portfolio of branded ingredients backed by a quality assurance program. The company also offers encapsulation and bottling services at its solar-powered California facility.
“The partnership with Ethical Naturals, which has built an impressive portfolio of differentiated nutraceutical ingredients with a unique focus on quality testing, is a perfect illustration of Solabia’s strategic direction as we sharpen our focus on high-value, science-backed ingredients,” said Muriel Koch, president and CEO of Solabia. “By combining these strengths with Solabia’s broader portfolio, international reach and innovation capabilities, we see significant opportunities to accelerate growth, particularly in the United States, and bring even more value to our customers.”
Two decades of development
ENI’s long-term priority for the partnership with Solabia is to build intellectual property and quality as foundations for each ingredient in its portfolio, said ENI CEO Cal Bewicke.
“It’s been twenty years since we founded ENI, and our mission of quality and ‘nature verified by science’ has remained the company’s cornerstone for all that time,” he said. “My partner (company co-founder Leo Lui) and I have felt for a while that it was time to grow ENI to the next level, to assure a productive future for the company, our employees and our customers. We saw that the best way to do this was through the development of a partnership with a company that has the same philosophy, ethics and product standards as ours.”
Cal Bewicke and Leo Liu will remain shareholders in the company and will continue to manage its development alongside Solabia.
Both ENI and Solabia focus on specialty ingredients. Several of ENI’s leading products are AlphaWave L-Theanine, Cranberex cranberry extract, and GreenGrown-GCS, vegan glucosamine and chondroitin blend while Solabia’s portfolio includes patented and clinically studied ingredients such as Bonolive high Oleuropein olive leaf extract, Microbiomex, standardized citrus and grapefruit extract, and Brainberry, a unique extract of Aronia melanocarpa.
“In Solabia, we have found a partner that shares our commitment to science, quality and innovation. We are excited about the opportunities ahead,” Bewicke said.




